BG60793B2 - Средство и метод за лечение на катаракта - Google Patents

Средство и метод за лечение на катаракта Download PDF

Info

Publication number
BG60793B2
BG60793B2 BG98554A BG9855494A BG60793B2 BG 60793 B2 BG60793 B2 BG 60793B2 BG 98554 A BG98554 A BG 98554A BG 9855494 A BG9855494 A BG 9855494A BG 60793 B2 BG60793 B2 BG 60793B2
Authority
BG
Bulgaria
Prior art keywords
bendazac
lysine salt
salt
cataracts
cortical
Prior art date
Application number
BG98554A
Other languages
Bulgarian (bg)
English (en)
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of BG60793B2 publication Critical patent/BG60793B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
BG98554A 1981-11-27 1994-02-24 Средство и метод за лечение на катаракта BG60793B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49790/81A IT1189052B (it) 1981-11-27 1981-11-27 Trattamento della cataratta

Publications (1)

Publication Number Publication Date
BG60793B2 true BG60793B2 (bg) 1996-03-29

Family

ID=11271573

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98554A BG60793B2 (bg) 1981-11-27 1994-02-24 Средство и метод за лечение на катаракта

Country Status (6)

Country Link
US (1) US4451477A (it)
JP (1) JPS5892612A (it)
BG (1) BG60793B2 (it)
GB (1) GB2110532B (it)
IT (1) IT1189052B (it)
YU (1) YU133882A (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194564B (it) * 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
EP0191520B1 (en) * 1985-02-12 1989-06-21 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them
US4665089A (en) * 1985-03-21 1987-05-12 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation using protein modification reagents
IT1197805B (it) * 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto
US5176714A (en) * 1986-08-01 1993-01-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Method of treating contact lenses
DE3883712T2 (de) * 1987-06-04 1993-12-16 Massachusetts Inst Technology Chemisches verhindern oder rückgängigmachen von star-erkrankungen durch phasentrennungsinhibitoren.
US5091421A (en) * 1987-06-04 1992-02-25 Massachusetts Institute Of Technology Chemical prevention or reversal of cataract by phase separation inhibitors
US5401880A (en) * 1987-06-04 1995-03-28 Oculon Corporation Chemical prevention or reversal of cataract by phase separation inhibitors
US5338545A (en) * 1987-06-04 1994-08-16 Oculon Corporation Chemical prevention or reversal of cataract by phase separation inhibitors
US5290813A (en) * 1987-06-04 1994-03-01 Massachusetts Institute Of Technology Chemical prevention or reversal of cataract by phase separation inhibitors
US4966577A (en) * 1988-03-16 1990-10-30 Allergan, Inc. Prevention of lens-related tissue growth in the eye
IT1230441B (it) 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1229674B (it) * 1989-04-26 1991-09-06 Acraf Composizione farmaceutica per uso topico oftalmico contenente bendazac o 5-0h bendazac
US5627162A (en) * 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
IT1293794B1 (it) * 1997-07-28 1999-03-10 Acraf Farmaco attivo nel ridurre la produzione di proteina mcp-1
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CN109481434B (zh) * 2018-12-18 2020-11-10 湖北远大天天明制药有限公司 滴眼剂、及其制备方法与应用
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN114796205B (zh) * 2021-04-30 2023-05-05 远大医药（中国）有限公司 用于治疗近视的方法和药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US27253A (en) * 1860-02-21 Engraver s vise
IL28032A (en) 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3625970A (en) * 1968-04-17 1971-12-07 Cutter Lab 1-(disubstituted phenyl or benzyl)-1h-indazol-3-yloxyacetic acid
IT1050741B (it) * 1975-12-01 1981-03-20 Acraf Utilizzazione degli acidi i benzil ih indazol 3 carbossilici sostituiti e loro derivati nel campo della contraccezione femminile
IT1131779B (it) * 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione

Also Published As

Publication number Publication date
GB2110532B (en) 1986-01-22
GB2110532A (en) 1983-06-22
JPH0368006B2 (it) 1991-10-25
JPS5892612A (ja) 1983-06-02
IT8149790A0 (it) 1981-11-27
US4451477A (en) 1984-05-29
YU133882A (en) 1985-04-30
IT1189052B (it) 1988-01-28

Similar Documents

Publication Publication Date Title
BG60793B2 (bg) Средство и метод за лечение на катаракта
ES2590259T3 (es) Compuestos y procedimientos para el tratamiento de convulsiones y trastornos paroxísticos
Nielsen et al. Transient excess urinary excretion of antidiuretic material in acute intermittent porphyria with hyponatremia and hypomagnesemia
US20130142888A1 (en) N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
BELLUR Opsoclonus: Its clinical value
WO1984002470A1 (en) Medicinal preparation for the therapeutic treatment of peptic ulcer
JPS62187412A (ja) ガングリオシツドの抽出法
EP2555771B1 (fr) Compositions pharmaceutiques fortement dosees en biotine
EP0373002B1 (en) Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
US20210206751A1 (en) Rotomeric Isomers of 4-alkyl-5-Heteroaryl-3H-1,2-Dithiole-3-Thiones
WO2018133139A1 (zh) 芍药苷-6'-o-苯磺酸酯在治疗干燥综合征的应用
CH651556A5 (en) Salt of (benzylindazolyl)oxyacetic acid, process for the preparation of this salt and pharmaceutical composition containing this salt
RU2406506C1 (ru) Фармацевтическая композиция холин альфосцерата в форме раствора для инъекций (холитилин®), обладающая ноотропной активностью и холиномиметическим действием, способ лечения/профилактики заболеваний цнс и последствий черепно-мозговых травм
Dam et al. Carbamazepine: a clinical biopharmaceutical study
CN104321323A (zh) 碳环核苷及其医药用途和组合物
JPS6310685B2 (it)
CN102210684B (zh) 四氢嘧啶及其衍生物在制备治疗白内障药物中的应用
Callaghan Asymmetrical dwarfism, or Silver's syndrome, in two male siblings
EP0652223A1 (en) 3-Oxygermylpropionic acid polymer
O'Brien et al. Idiopathic hypercalcemia of infancy
RU2252778C1 (ru) Применение трипептида pro-gly-pro в качестве средства профилактики и лечения диабета, способ профилактики и лечения диабета и фармацевтическая композиция для профилактики и лечения диабета
US20030118597A1 (en) Process for production of bee venom as pharmaceutical product which can be used effectively in the treatment of rheumatoid arthritis and viral diseases
US20230338464A1 (en) Use of anti-aging glycopeptides for treatment of dry eye disease, retinal degenerative diseases, or occular inflammation
RU2362554C2 (ru) Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства
US20230255961A1 (en) Rotomeric Isomers of 4-Alkyl-5-Heteroaryl-3H-1,2-Dithiole-3-Thiones